We tested the performance of low- and medium-pressure PS flow control valves as they were perfused with (1) solutions with varying concentrations of protein, (2) solutions with varying numbers of red blood cells (RBC) or (3) solutions with varying concentrations of whole blood. Perfusion was performed with a peristaltic pump at a constant rate and each trial lasted 2 weeks or until valve failure. Mean valve pressures were measured and recorded electronically, and opening and closing pressures were obtained at baseline and at the end of the perfusion period or upon valve failure. Any buildup of material within the valve was noted and recorded. Our findings were as follows: (1) protein levels have little practical effect on valve function; (2) moderate numbers of RBC cause increased variability in valve function while large numbers of RBC uniformly lead to valve failure; (3) prolonged perfusion with solutions of dilute whole blood is poorly tolerated, and (4) valve failure is preceded by a period of increased variability in perfusion pressure.

1.
Rayport M, Reiss J: Hydrodynamic properties of certain shunt assemblies for the treatment of hydrocephalus. J Neurosurg 1969;30:455–467.
2.
Hakim S, Duran de la Roche F, Burton JD: A critical analysis of valve shunts used in the treatment of hydrocephalus. Dev Med Child Neurol 1973;15:230–255.
3.
Trost HA, Heissler HE, Claussen G, Gaab MR: Testing the hydrocephalus shunt valve: Long-term bench test results of various new and explanted valves. The need for a model for testing valves under physiological conditions. Eur J Pediatr Surg 1991;1(suppl 1):38–40.
4.
Sainte-Rose C, Hooven MD, Hirsch JF: A new approach in the treatment of hydrocephalus. J Neurosurg 1987;66:213–226.
5.
Pudenz RH: CSF-Protein Study: Medical Education Series Pamphlet. Goleta, PS Medical Corporation, 1992.
6.
Brydon HL, Bayston R, Hayward R, Harkness W: The effect of protein and blood cells on the flow-pressure characteristics of shunts. Neurosurgery 1996;38:498–505.
7.
Brydon HL, Hayward R, Harkness W, Bayston R: Physical properties of cerebrospinal fluid of relevance to shunt function. 1. The effect of protein upon CSF viscosity. Br J Neurosurg 1995;9:639–644.
8.
Brydon HL, Hayward R, Harkness W, Bayston R: Physical properties of cerebrospinal fluid of relevance to shunt function. 2. The effect of protein upon CSF surface tension and contact angle. Br J Neurosurg 1995;9:645–653.
9.
Brydon HL, Hayward R, Harkness W, Bayston R: Does the cerebrospinal fluid protein concentration increase the risk of shunt complications? Br J Neurosurg 1996;10:267–273.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.